120 related articles for article (PubMed ID: 8104684)
61. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
62. Absence of gamma-glutamyltranspeptidase activity in lung metastasis in rats with hepatocellular carcinomas induced by ciprofibrate, a peroxisome proliferator.
Milano M; Reddy JK; Prasad JD; Rao MS
Cancer Lett; 1987 Dec; 38(1-2):65-71. PubMed ID: 2891433
[TBL] [Abstract][Full Text] [Related]
63. Effects of a high-sucrose diet on the development of enzyme-altered foci in chemical hepatocarcinogenesis in rats.
Hei TK; Sudilovsky O
Cancer Res; 1985 Jun; 45(6):2700-5. PubMed ID: 2859110
[TBL] [Abstract][Full Text] [Related]
64. Quantitative stereological evaluation of four histochemical markers of altered foci in multistage hepatocarcinogenesis in the rat.
Hendrich S; Campbell HA; Pitot HC
Carcinogenesis; 1987 Sep; 8(9):1245-50. PubMed ID: 2887301
[TBL] [Abstract][Full Text] [Related]
65. Activated Kupffer cells attenuate the liver response to the peroxisome proliferator perfluorooctanoic acid.
Youssef J; Badr M
Mol Cell Biochem; 1997 Apr; 169(1-2):143-7. PubMed ID: 9089641
[TBL] [Abstract][Full Text] [Related]
66. Immunotoxic and hepatotoxic effects of perfluoro-n-decanoic acid (PFDA) on female Harlan Sprague-Dawley rats and B
Frawley RP; Smith M; Cesta MF; Hayes-Bouknight S; Blystone C; Kissling GE; Harris S; Germolec D
J Immunotoxicol; 2018 Dec; 15(1):41-52. PubMed ID: 29514525
[TBL] [Abstract][Full Text] [Related]
67. Characterization of the hepatic responses to the short-term administration of ciprofibrate in several rat strain. Co-induction of microsomal cytochrome P-450 IVA1 and peroxisome proliferation.
Makowska JM; Anders C; Goldfarb PS; Bonner F; Gibson GG
Biochem Pharmacol; 1990 Sep; 40(5):1083-93. PubMed ID: 2390105
[TBL] [Abstract][Full Text] [Related]
68. Perfluorodecanoic acid enhances the formation of oleic acid in rat liver.
Yamamoto A; Kawashima Y
Biochem J; 1997 Jul; 325 ( Pt 2)(Pt 2):429-34. PubMed ID: 9230124
[TBL] [Abstract][Full Text] [Related]
69. Effects of the hepatocarcinogen nafenopin, a peroxisome proliferator, on the activities of rat liver glutathione-requiring enzymes and catalase in comparison to the action of phenobarbital.
Furukawa K; Numoto S; Furuya K; Furukawa NT; Williams GM
Cancer Res; 1985 Oct; 45(10):5011-9. PubMed ID: 2862989
[TBL] [Abstract][Full Text] [Related]
70. The natural history of neoplasia. Newer insights into an old problem.
Pitot HC
Am J Pathol; 1977 Nov; 89(2):402-11. PubMed ID: 21565
[TBL] [Abstract][Full Text] [Related]
71. Developmental toxicity of perfluorodecanoic acid in C57BL/6N mice.
Harris MW; Birnbaum LS
Fundam Appl Toxicol; 1989 Apr; 12(3):442-8. PubMed ID: 2731659
[TBL] [Abstract][Full Text] [Related]
72. Effect of rodent hepatocarcinogenic peroxisome proliferators on fatty acyl-CoA oxidase, DNA synthesis, and apoptosis in cultured human and rat hepatocytes.
Perrone CE; Shao L; Williams GM
Toxicol Appl Pharmacol; 1998 Jun; 150(2):277-86. PubMed ID: 9653058
[TBL] [Abstract][Full Text] [Related]
73. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis.
Yeldandi AV; Rao MS; Reddy JK
Mutat Res; 2000 Mar; 448(2):159-77. PubMed ID: 10725470
[TBL] [Abstract][Full Text] [Related]
74. Synergistic effect of a choline-devoid diet and phenobarbital in promoting the emergence of foci of gamma-glutamyltranspeptidase-positive hepatocytes in the liver of carcinogen-treated rats.
Shinozuka H; Lombardi B
Cancer Res; 1980 Oct; 40(10):3846-9. PubMed ID: 6108159
[TBL] [Abstract][Full Text] [Related]
75. Inhibition by pentachlorophenol of the initiating and promoting activities of 1'-hydroxysafrole for the formation of enzyme-altered foci and tumors in rat liver.
Boberg EW; Liem A; Miller EC; Miller JA
Carcinogenesis; 1987 Apr; 8(4):531-9. PubMed ID: 2881629
[TBL] [Abstract][Full Text] [Related]
76. Dual action of peroxisome proliferator-activated receptor alpha in perfluorodecanoic acid-induced hepatotoxicity.
Luo M; Tan Z; Dai M; Song D; Lin J; Xie M; Yang J; Sun L; Wei D; Zhao J; Gonzalez FJ; Liu A
Arch Toxicol; 2017 Feb; 91(2):897-907. PubMed ID: 27344344
[TBL] [Abstract][Full Text] [Related]
77. Characteristics of dehydroepiandrosterone as a peroxisome proliferator.
Yamada J; Sakuma M; Ikeda T; Fukuda K; Suga T
Biochim Biophys Acta; 1991 Apr; 1092(2):233-43. PubMed ID: 1673353
[TBL] [Abstract][Full Text] [Related]
78. Enhancement of peroxisomal enzymes, cytochrome P-452 and DNA synthesis in putative preneoplastic foci of rat liver treated with the peroxisome proliferator nafenopin.
Grasl-Kraupp B; Huber W; Just W; Gibson G; Schulte-Hermann R
Carcinogenesis; 1993 May; 14(5):1007-12. PubMed ID: 8099311
[TBL] [Abstract][Full Text] [Related]
79. Modulation of selenium-dependent glutathione peroxidase by perfluorodecanoic acid in rats: effect of dietary selenium.
Chen LC; Borges T; Glauert HP; Knight SA; Sunde RA; Schramm H; Oesch F; Chow CK; Robertson LW
J Nutr; 1990 Mar; 120(3):298-304. PubMed ID: 2181083
[TBL] [Abstract][Full Text] [Related]
80. Menhaden oil inhibited gamma-glutamyltransferase-positive altered hepatic foci in female Sprague-Dawley rats.
Lee SO; Liu H; Cunnick JE; Murphy PA; Hendrich S
Nutr Cancer; 2002; 44(1):71-9. PubMed ID: 12672644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
